RLMD - Relmada Therapeutics Inc Revenue Breakdown

Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

Peers: URGN CGON ENGN TARA ARTV SPTX ZVRA XENE RZLT ACAD

| Held by: VTI IWM VXF XPH IWO PSIL VTWO IWC FESM VHT

Scroll to Statements

Index	RUT
Market Cap	404.81M
Enterprise Value	187.08M
Income	-61.93M
Sales	0.00M
Book/sh	1.94
Cash/sh	2.04
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	17
IPO	Jun 20, 2014

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.96
P/C	1.86
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	29.52
Current Ratio	29.52
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.93
EPS next Y	-0.80
EPS next Q	-0.14
EPS this Y	57.07%
EPS next Y	-28.11%
EPS next 5Y	20.09%
EPS past 3/5Y	35.03% 17.54%
Sales past 3/5Y	- -
EPS Y/Y TTM	57.98%
Sales Y/Y TTM	-
EPS Q/Q	61.35%
Sales Q/Q	-
Earnings	Aug 06 AMC
EPS/Sales Surpr.	44.86% -

Insider Own	13.01%
Insider Trans	2.97%
Inst Own	84.62%
Inst Trans	16.64%
ROA	-51.57%
ROE	-55.66%
ROIC	-29.98%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	14.32%
SMA50	-0.82%
SMA200	-29.16%
Trades

Shs Outstand	106.67M
Shs Float	92.79M
Short Float	13.13%
Short Ratio	9.16
Short Interest	12.18M
52W High	8.00 -52.56%
52W Low	2.15 76.51%
Volatility	6.01% 6.36%
ATR (14)	0.22
RSI (14)	59.55
Beta	0.62
Rel Volume	1.00
Avg Volume	1.33M
Volume	865,347

Perf Week	17.49%
Perf Month	5.42%
Perf Quarter	-30.62%
Perf Half Y	-48.79%
Perf YTD	-21.43%
Perf Year	67.92%
Perf 3Y	24.43%
Perf 5Y	-84.83%
Perf 10Y	-10.50%
Recom	1.00
Target Price	10.75
Prev Close	3.58
Price	3.80
Change %	6.01%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)